PhorMax gets FDA clearance and new exec

Article

Privately held developer of low-cost CR systems PhorMax got good news and a new leader this month. The company announced Jan. 15 that the FDA had cleared its low-cost CR system, called Phormax CR. Just days earlier, the company welcomed Marvin Slosman as

Privately held developer of low-cost CR systems PhorMax got good news and a new leader this month. The company announced Jan. 15 that the FDA had cleared its low-cost CR system, called Phormax CR. Just days earlier, the company welcomed Marvin Slosman as its new president and CEO.

Slosman last served as executive vice president at Emerge Interactive, a business-to-business e-commerce market maker. While there, he guided Emerge from an early-stage startup to a successful IPO, developing and executing a strategic business plan that grew revenue from $3 million to $100 million. Along the way, the company made 11 acquisitions and partnerships. Prior to joining the B2B company, Slosman was cardiology division sales manager at Cordis, a Johnson & Johnson company. Earlier he served as vice president of business development and sales programs for GE Capital.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.